Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Summary
The global Fetal Bovine Serum (FBS) Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
Fetal bovine serum (FBS) is the liquid fraction of the blood extracted from a bovine fetus through a closed system of collection at the slaughterhouse. Fetal bovine serum is a majorly used serum supplement for the in vitro culture of eukaryotic cells. FBS contains a variety of molecules such as hormones, acids, sugars, and lipids. The global fetal bovine serum market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global fetal bovine serum market is expected to witness significant growth during the forecast period rising demand for biopharmaceuticals across the globe.
Market Drivers
Increasing research and development activities in biotech is expected to drive growth of the global fetal bovine serum market during the forecast period. Many biopharmaceutical and biotech companies are actively investing in research and development activities, especially in emerging economies such as China and India, in order to innovate novel products in the field of fetal bovine serum. For instance, in September 2019, Mylan N.V. invested US$ 1 billion Capex in India. Thus, these factors are expected to drive growth of the global fetal bovine serum market during the forecast period. Moreover, growing demand for biopharmaceuticals combined with rising support from the government for research activities is expected to propel the global fetal bovine serum market growth over the forecast period.
Market Restraint
Significant rise in price in the recent past is expected to restrain growth of the global fetal bovine serum market during the forecast period.
Regional Insights
Among regions, North America is expected to witness significant growth in the global fetal bovine serum market during the forecast period. This is owing to increasing research and development activities in biotechnology in the region. Moreover, Asia Pacific is expected to register a lucrative growth rate over the forecast period, owing to rising government initiatives to improve the R&D activities biotechnology sector.
Competitive Section
Key players operating in the global fetal bovine serum market are Thermo Fisher, Animal Technologies, Jin Yuan Kang, GE Healthcare, ExCell Bio, Sigma-Aldrich, Zhejiang Tianhang Biotechnology, Merck, Lanzhou Minhai, Moregate BioTech, Bio Nutrientes Brasil, Gemini, NorthBio, Atlanta Biologicals, Seroxlab, Tissue Culture Biologicals, Peak Serum, Bovogen, Seroxlab, Biowest, Peak Serum, Internegocios, WISENT, RMBIO, Serana, Biological Industries, Animal Technologies, and VWR.
Key companies in the market are focused on partnerships and collaborations, in order to enhance the market presence. For instance, in July 2017, GE Healthcare partnered with Oritain to launch an independent test-based traceability program to authenticate the country of origin of fetal bovine serum.
The Fetal Bovine Serum (FBS) Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Fetal Bovine Serum (FBS) Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Thermo Fisher
- GE Healthcare
- Sigma-Aldrich
- Merck
- Moregate BioTech
- Gemini
- Atlanta Biologicals
- Tissue Culture Biologicals
- Bovogen
- Biowest
- Internegocios
- RMBIO
- Biological Industries
- PAN-Biotech
- VWR
- Corning
By the Product Type, the market is primarily segmented into:
- North America-sourced
- South America-sourced
- Australia-sourced
- Others
By Applications, the market is segmented into:
- Research & Development
- Commercial Production
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Fetal Bovine Serum (FBS) Market Report:
- To assess the size of the market by value and volume
- Analyze the Fetal Bovine Serum (FBS) Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Fetal Bovine Serum (FBS) Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Fetal Bovine Serum (FBS) Market
The Fetal Bovine Serum (FBS) Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Fetal Bovine Serum (FBS) Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
